109 related articles for article (PubMed ID: 37280993)
1. Complex Cell Type-Specific Transcriptional Regulation by the Promoter and an Intron of the Mouse P-Cadherin Gene: (P-cadherin/cell adhesion molecule/transcriptional regulation).
Hatta M; Takeichi M
Dev Growth Differ; 1994 Oct; 36(5):509-519. PubMed ID: 37280993
[TBL] [Abstract][Full Text] [Related]
2. Analysis of regulatory elements of E-cadherin with reporter gene constructs in transgenic mouse embryos.
Stemmler MP; Hecht A; Kinzel B; Kemler R
Dev Dyn; 2003 Jun; 227(2):238-45. PubMed ID: 12761851
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter.
Bussemakers MJ; Giroldi LA; van Bokhoven A; Schalken JA
Biochem Biophys Res Commun; 1994 Sep; 203(2):1284-90. PubMed ID: 8093045
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin intron 2 contains cis-regulatory elements essential for gene expression.
Stemmler MP; Hecht A; Kemler R
Development; 2005 Mar; 132(5):965-76. PubMed ID: 15673570
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis.
Faraldo ML; Rodrigo I; Behrens J; Birchmeier W; Cano A
Mol Carcinog; 1997 Sep; 20(1):33-47. PubMed ID: 9328434
[TBL] [Abstract][Full Text] [Related]
6. Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity.
Whyte DA; Li C; Thomson RB; Nix SL; Zanjani R; Karp SL; Aronson PS; Igarashi P
Am J Physiol; 1999 Oct; 277(4):F587-98. PubMed ID: 10516284
[TBL] [Abstract][Full Text] [Related]
7. The SLUG zinc-finger protein represses E-cadherin in breast cancer.
Hajra KM; Chen DY; Fearon ER
Cancer Res; 2002 Mar; 62(6):1613-8. PubMed ID: 11912130
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
[TBL] [Abstract][Full Text] [Related]
10. Identification of the promoter and a transcriptional enhancer of the gene encoding L-CAM, a calcium-dependent cell adhesion molecule.
Sorkin BC; Jones FS; Cunningham BA; Edelman GM
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11356-60. PubMed ID: 8248253
[TBL] [Abstract][Full Text] [Related]
11. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
12. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
Rodrigo I; Cato AC; Cano A
Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
[TBL] [Abstract][Full Text] [Related]
13. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element.
Behrens J; Löwrick O; Klein-Hitpass L; Birchmeier W
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11495-9. PubMed ID: 1763063
[TBL] [Abstract][Full Text] [Related]
14. Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene.
Sternberg EA; Spizz G; Perry WM; Vizard D; Weil T; Olson EN
Mol Cell Biol; 1988 Jul; 8(7):2896-909. PubMed ID: 3405222
[TBL] [Abstract][Full Text] [Related]
15. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
17. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
18. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
Jarrard DF; Paul R; van Bokhoven A; Nguyen SH; Bova GS; Wheelock MJ; Johnson KR; Schalken J; Bussemakers M; Isaacs WB
Clin Cancer Res; 1997 Nov; 3(11):2121-8. PubMed ID: 9815605
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
Lombaerts M; van Wezel T; Philippo K; Dierssen JW; Zimmerman RM; Oosting J; van Eijk R; Eilers PH; van de Water B; Cornelisse CJ; Cleton-Jansen AM
Br J Cancer; 2006 Mar; 94(5):661-71. PubMed ID: 16495925
[TBL] [Abstract][Full Text] [Related]
20. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.
Kim MA; Jung EJ; Lee HS; Lee HE; Yang HK; Oh DY; Bang YJ; Kim WH
Hum Pathol; 2010 Jun; 41(6):877-85. PubMed ID: 20233621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
